- Home
- ARWR vs IESC Comparison
ARWR vs IESC Comparison
Compare ARWR & IESC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | IESC |
|---|---|---|
| Founded | 2003 | 1997 |
| Country | United States | United States |
| Employees | N/A | 10283 |
| Industry | Biotechnology: Pharmaceutical Preparations | Engineering & Construction |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 13.3B |
| IPO Year | 2009 | 1997 |
Fundamental Metrics
Financial Performance| Metric | ARWR | IESC |
|---|---|---|
| Price | $85.30 | $313.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 1 |
| Target Price | $83.40 | ★ $458.00 |
| AVG Volume (30 Days) | ★ 1.1M | 180.9K |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 99.80 | 51.87 |
| EPS | N/A | ★ 17.52 |
| Revenue | $16,142,321.00 | ★ $3,371,468,000.00 |
| Revenue This Year | N/A | $22.20 |
| Revenue Next Year | N/A | $14.88 |
| P/E Ratio | ★ N/A | $19.05 |
| Revenue Growth | N/A | ★ 16.89 |
| 52 Week Low | $22.73 | $307.12 |
| 52 Week High | $95.49 | $816.51 |
Technical Indicators
Market Signals| Indicator | ARWR | IESC |
|---|---|---|
| Relative Strength Index (RSI) | 48.61 | 25.68 |
| Support Level | $82.70 | N/A |
| Resistance Level | $87.83 | $496.74 |
| Average True Range (ATR) | 2.65 | 32.49 |
| MACD | -0.40 | -50.31 |
| Stochastic Oscillator | 26.08 | 4.97 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
About IESC IES Holdings Inc.
IES Holdings Inc owns and manages subsidiaries that design and installs integrated electrical and technology systems and provide infrastructure products and services. It has four business segments; Communications, Residential, Infrastructure Solutions, and Commercial & Industrial. The majority of the revenue for the company is generated from its Residential segment in which the company provides electrical installation services for single-family housing and multi-family apartment complexes, as well as heating, ventilation, and air conditioning (HVAC) and plumbing installation services. This segment also provides services for installing residential solar power, both for new construction and existing residences.